Actively Recruiting

Age: 18Years - 70Years
All Genders
Healthy Volunteers
ID07357272

A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment

Led by Beijing Anzhen Hospital · Updated on 2026-01-21

200

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating how Continuous Positive Airway Pressure (CPAP) treatment affects blood pressure in adults aged 18 to 70 who have obstructive sleep apnea (OSA) and high or uncontrolled blood pressure. The study aims to find out which patients benefit the most in blood pressure reduction from CPAP and whether adding a sleep aid medication can improve CPAP effectiveness for those who experience insomnia or frequent awakenings at night. This observational study is sponsored by Beijing Anzhen Hospital and focuses on blood pressure control and sleep quality in OSA patients. Participants will use an auto-titrating CPAP device for at least 4 hours each night and at least 21 nights per month over about 3 months, with fitted masks and support to encourage use. Those with difficulty sleeping may also choose to take a short course of sleep aid medication (trazodone or zopiclone) for 4 weeks. The study forms natural sub-groups based on these interventions: CPAP only, CPAP plus trazodone, CPAP plus zopiclone, or drug only for those who decline CPAP. During the study, participants will undergo full-night sleep monitoring and 24-hour blood pressure monitoring to tailor CPAP pressure. Researchers will use questionnaires, actigraphy wristwatches, and additional sleep studies to observe changes in sleep and blood pressure. Blood and urine samples will be collected for safety checks. Participants are free to withdraw anytime without penalty, and study-related care including devices, medications, and tests are provided at no cost. The primary outcome measured is blood pressure after 3 months of CPAP treatment.

CONDITIONS

Brief Title

A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment

Who Can Participate

Age: 18Years - 70Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 70 years old
  • Diagnosed with obstructive sleep apnea by overnight polysomnography with either AHI 65 plus symptoms or AHI 615 per hour
  • Have office blood pressure between 120-159/80-99 mmHg or are on stable blood pressure medication but not at target
  • Able to tolerate 24-hour ambulatory and continuous blood pressure monitoring
Not Eligible

You will not qualify if you...

  • Previously diagnosed with obstructive sleep apnea and currently receiving treatment such as CPAP or surgery
  • Having secondary hypertension from other causes like kidney disease or Cushing's syndrome
  • Unstable health conditions including recent cardiovascular events, severe sleepiness, cognitive impairment, active mental illness, or substance abuse
  • Rheumatic immune diseases or malignant tumors
  • Large artery diseases such as arterial dissection or aneurysm
  • Conditions preventing accurate blood pressure measurement like atrial fibrillation
  • Early-onset familial hypertension
  • Use of sleep aid medications within 4 weeks before enrollment
  • Allergy or contraindication to study drugs (trazodone, zopiclone)
  • Pregnant, breastfeeding, or planning pregnancy
  • Working night shifts 3 or more nights per week or diagnosed circadian rhythm disorder
  • Participating in other interventional clinical trials

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 3 months

Participants undergo auto-titrating continuous positive airway pressure (CPAP) treatment for 3 months with mask-fitting, education, and side-effect management to maximize adherence. Some participants may receive additional 4-week bedtime medication at physician discretion.

Regular visits for mask-fitting, education, and side-effect management during treatment

Long-term Monitoring

Duration - Post 3 months of CPAP treatment

Participants are observed for changes in blood pressure and sleep quality after completing CPAP treatment.

1 to 2 visits depending on assessments

Trial Site Locations

Total: 1 location

1

Anzhen Hospital, Capital Medical University

Beijing, Beijing Municipality, China, 100069

Actively Recruiting

Loading map...

Research Team

J

Jiang Xie, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Randomized, Parallel, Two-Arm Study Comparing the Net Clin...

Hypertension (HTN)

Actively Recruiting

1 location

Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patc...

Blood Pressure

Actively Recruiting

10 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

New perspective on exploring the predictive factors of blood pressure reduction during CPAP treatment in people with severe OSA and hypertension: a prospective observational study.

Zili Meng, Ying Chen, Ting Yang...

https://pubmed.ncbi.nlm.nih.gov/37169401

Long-Term Effect of Obstructive Sleep Apnea and Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients with Acute Coronary Syndrome: A Clinical Trial.

Manuel Sánchez-de-la-Torre, Esther Gracia-Lavedan, Iván David Benítez...

https://pubmed.ncbi.nlm.nih.gov/35442180

Efficacy of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH): Systematic review and meta-analysis.

Gonzalo Labarca, Alexia Schmidt, Jorge Dreyse...

https://pubmed.ncbi.nlm.nih.gov/33607443